247 related articles for article (PubMed ID: 28715437)
1. High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
Silva EM; Mariano VS; Pastrez PRA; Pinto MC; Castro AG; Syrjanen KJ; Longatto-Filho A
PLoS One; 2017; 12(7):e0181125. PubMed ID: 28715437
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.
Barrera L; Montes-Servín E; Barrera A; Ramírez-Tirado LA; Salinas-Parra F; Bañales-Méndez JL; Sandoval-Ríos M; Arrieta Ó
Ann Oncol; 2015 Feb; 26(2):428-35. PubMed ID: 25467015
[TBL] [Abstract][Full Text] [Related]
3. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cytokine modulation in non-small cell lung cancer.
Neuner A; Schindel M; Wildenberg U; Muley T; Lahm H; Fischer JR
Int J Cancer; 2002 Sep; 101(3):287-92. PubMed ID: 12209981
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer.
Brussino L; Culla B; Bucca C; Giobbe R; Boita M; Isaia G; Heffler E; Oliaro A; Filosso P; Rolla G
J Breath Res; 2014 Jun; 8(2):027110. PubMed ID: 24861949
[TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.
Chang CH; Hsiao CF; Yeh YM; Chang GC; Tsai YH; Chen YM; Huang MS; Chen HL; Li YJ; Yang PC; Chen CJ; Hsiung CA; Su WC
Int J Cancer; 2013 May; 132(9):1977-85. PubMed ID: 23034889
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
9. Significance of the correlation between the expression of interleukin 6 and clinical features in patients with non-small cell lung cancer.
Koh E; Iizasa T; Yamaji H; Sekine Y; Hiroshima K; Yoshino I; Fujisawa T
Int J Surg Pathol; 2012 Jun; 20(3):233-9. PubMed ID: 22334615
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
Migdalska-Sęk M; Góralska K; Jabłoński S; Kordiak J; Nawrot E; Kiszałkiewicz JM; Pastuszak-Lewandoska D; Baran K; Stuss M; Brzeziańska-Lasota E
Mol Biol Rep; 2020 Jan; 47(1):583-592. PubMed ID: 31707599
[TBL] [Abstract][Full Text] [Related]
11. Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease.
Liao C; Yu ZB; Meng G; Wang L; Liu QY; Chen LT; Feng SS; Tu HB; Li YF; Bai L
Cancer; 2015 Sep; 121 Suppl 17():3122-9. PubMed ID: 26331819
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis.
Orditura M; De Vita F; Catalano G; Infusino S; Lieto E; Martinelli E; Morgillo F; Castellano P; Pignatelli C; Galizia G
J Interferon Cytokine Res; 2002 Nov; 22(11):1129-35. PubMed ID: 12513912
[TBL] [Abstract][Full Text] [Related]
13. [Cytokine responses after lobectomy: a prospective randomized comparison of video-assisted thoracoscopic surgery and minimal incision thoracotomy].
Long H; Lin ZC; Situ DR; He LR; Yan SL; Lin YB; Rong TH
Ai Zheng; 2007 Sep; 26(9):991-5. PubMed ID: 17927859
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
16. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
17. CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Fontanini G
Hum Pathol; 2007 Oct; 38(10):1563-8. PubMed ID: 17651784
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
19. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Hao K; Yu L; Zhang X
Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]